Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.
Early Phase 1
Completed
- Conditions
- HIV InfectionsAIDS/HIV - RelatedDisease Associated With AIDSVaccine-Preventable Diseases
- Interventions
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Uvax Bio LLC
- Target Recruit Count
- 34
- Registration Number
- NCT06541093
- Locations
- 🇦🇺
Nucleus Network Melbourne, Melbourne, Victoria, Australia
News
No news found